Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Proteome Sciences plc    PRM   GB0003104196

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/23/2015 01/26/2015 01/27/2015 01/28/2015 01/29/2015 Date
25.5(c) 24.5(c) 24.5(c) 24.25(c) 23.295 Last
127 813 82 844 962 738 48 254 68 336 Volume
+3.55% -3.92% 0.00% -1.02% -3.94% Change
More quotes
Company
Proteome Sciences Plc is a protein biomarker discovery service company.It offers sensitivity, proprietary technologies for protein and peptide biomarker discovery, validation and assay development.Its PS biomarker services uses isobaric and isotopic Tandem Mass Tag workflows developed on the latest... 
More about the company
Chart PROTEOME SCIENCES PLC
Duration : Period :
Proteome Sciences plc Technical Analysis Chart | PRM | GB0003104196 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 1,74 M
EBIT 2014 -4,00 M
Net income 2014 -3,54 M
Debt 2014 6,63 M
Yield 2014 -
Sales 2015 2,22 M
EBIT 2015 -3,76 M
Net income 2015 -3,33 M
Debt 2015 9,34 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 33,6x
EV / Sales 2015 27,6x
Capitalization 51,9 M
More Financials
Latest news on PROTEOME SCIENCES PLC
2014 PROTEOME SCIENCES : Mr. James Malthouse has retired as a director of the Company..
2014 PROTEOME SCIENCES : Positive Results From Pancreatic Cancer Study Using SysQuant
2014 PROTEOME SCIENCES : SysQuant® – Update/Contract Awards
2014 Solo Oil's exploration licence deal approved
2014 PROTEOME SCIENCES : Says Revenue Will Not Meet Market Expectations
2014 PROTEOME SCIENCES : Trading Update
2014 PROTEOME SCIENCES : Announces Appointment of Non-Executive Director
2014 PROTEOME SCIENCES : Appoints Geoffrey Ellis As Finance Director, Loss Widens
More news
Sector news Bio Therapeutic Drugs
01/28 INCYTE : Announces Publication of Phase III RESPONSE Trial in Patients with Poly..
01/28 QIAGEN NV : Reports Results for Fourth Quarter and Full-Year 2014
01/27 QIAGEN NV : Introduces QuantiFERON Monitor® for Tracking Immune Function in Soli..
Plus d'actualités du secteur Bio Therapeutic Drugs


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF